Antonio Toscano
Overview
Explore the profile of Antonio Toscano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
234
Citations
2875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atanasio G, Bertino S, Velo M, Tessitore A, Zaccone C, Masaracchio A, et al.
J Neurol
. 2025 Mar;
272(3):251.
PMID: 40047950
Cerebral foreign body reaction (CFBR) due to hydrophilic polymer embolization is a rarely diagnosed complication of cerebral endovascular procedures. Despite the considerable use of endovascular treatment in the literature, few...
2.
Porcino M, Guccione F, Usbergo C, Navarra G, Toscano A, Musumeci O
Acta Myol
. 2025 Feb;
43(4):145-148.
PMID: 40017291
Objective: This case study aimed to evaluate the safety and efficacy of sleeve gastrectomy surgery in an obese patient with Late-onset Pompe disease (LOPD) and to explore the potential role...
3.
Romoli M, Urbinati G, Tudisco V, Toscano A, Eusebi P, Giammello F, et al.
Neurology
. 2025 Feb;
104(6):e213426.
PMID: 39999395
Background And Objectives: The risk of recurrent ischemic stroke, intracranial hemorrhage, and mortality in people with atrial fibrillation detected after stroke (AFDAS) is still unclear compared with people with known...
4.
Discalzi A, Nardelli F, Brino J, Toscano A, Simonato E, Rossato D
J Vasc Interv Radiol
. 2025 Feb;
36(3):544-545.
PMID: 39984278
No abstract available.
5.
Kushlaf H, Bratkovic D, Byrne B, Claeys K, Diaz-Manera J, Dimachkie M, et al.
Neurology
. 2025 Feb;
102(7_supplement_1):3348.
PMID: 39977945
Objective: To analyze within-group effect sizes of cipaglucosidase alfa plus miglustat (cipa+mig) and alglucosidase alfa (alg) for efficacy, quality of life (QoL), and biomarker variables in ERT-experienced patients. Background: The...
6.
Toscano A, Bonomo L, Capuano P, Cremascoli L, Castelli F, Puppo M, et al.
Surg Laparosc Endosc Percutan Tech
. 2025 Feb;
PMID: 39925224
Background: Diastasis recti abdominis (DRA) is a prevalent postpartum condition characterized by the separation of the rectus abdominis muscles with an interrectal distance >2.5 cm, often leading to symptoms like...
7.
Boon P, Berger T, Leonardi M, Marson T, Kallweit U, Moro E, et al.
Eur J Neurol
. 2025 Jan;
32(1):e16589.
PMID: 39815708
Background And Purpose: The global burden of neurological diseases exceeds 43.1%, imposing a significant burden on patients, caregivers and society. This paper presents a roadmap to reduce this burden and...
8.
Karaa A, Bertini E, Carelli V, Cohen B, Ennes G, Falk M, et al.
Orphanet J Rare Dis
. 2024 Nov;
19(1):431.
PMID: 39574155
Background: As previously published, the MMPOWER-3 clinical trial did not demonstrate a significant benefit of elamipretide treatment in a genotypically diverse population of adults with primary mitochondrial myopathy (PMM). However,...
9.
Silvetti S, Paternoster G, Abelardo D, Ajello V, Aloisio T, Baiocchi M, et al.
Minerva Anestesiol
. 2024 Nov;
90(11):957-968.
PMID: 39545652
Introduction: Enhanced recovery after cardiac surgery in selected low-risk patients, has the potential to improve outcomes and reduce the burden of healthcare costs. Anesthesia-related challenges play a major role in...
10.
Kishnani P, Byrne B, Claeys K, Diaz-Manera J, Dimachkie M, Kushlaf H, et al.
J Patient Rep Outcomes
. 2024 Nov;
8(1):132.
PMID: 39535661
Background: Late-onset Pompe disease (LOPD), a rare autosomal recessive multisystemic disorder, substantially impacts patients' day-to-day activities, outcomes, and health-related quality of life (HRQoL). The PROPEL trial compared cipaglucosidase alfa plus...